Aigen Investment Management, LP Legend Biotech Corp Transaction History

Aigen Investment Management, LP

  • $498 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
SELL
$63.16 - $76.5 $541,344 - $655,681
-8,571 Reduced 64.27%
4,765 $320,000
Q2 2023

Aug 14, 2023
BUY
$46.28 - $75.01 $617,190 - $1 Million
13,336 New
13,336 $920,000
Q3 2021

Nov 12, 2021
SELL
$35.31 - $50.56 $198,724 - $284,551
-5,628 Closed
0 $0
Q2 2021

Aug 10, 2021
BUY
$25.8 - $41.09 $145,202 - $231,254
5,628 New
5,628 $231,000

Others Institutions Holding LEGN

# of Institutions
198
Shares Held
74.2M
Call Options Held
374K
Put Options Held
387K
View Full List

About Legend Biotech Corp

LEGN Quotes by TradingView
  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $8.5B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Aigen Investment Management, LP Portfolio

Follow Aigen Investment Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Aigen Investment Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email